We also present our perspectives on how the loss and gain of GC-C mediated signaling may be linked to CRC and IBD and how these seemingly disparate conditions may help broaden our understanding of the cellular roles of GC-C/cGMP signaling in health and disease. Here, GUCY2C is linked to irritable bowel syndrome.